有组织结直肠癌筛查对大型社区人群癌症发病率和死亡率的影响
在大型社区人群中,2007至2008年实施以年度粪便免疫化学检测和结肠镜为主的有组织结直肠癌筛查。筛查达标率从2000年38.9%升至2015年82.7%(P<.01),结直肠癌年发病率降低25.5%、死亡率降低52.4%(均P<.01)。
要点
- 筛查达标率从2000年38.9%升至2015年82.7%(P<.01)。
- 结直肠癌年发病率从95.8降至71.4例/10万,降低25.5%(P<.01)。
- 结直肠癌死亡率从30.9降至14.7例/10万,降低52.4%(P<.01)。
核心结论
- 在大型社区人群中实施有组织结直肠癌筛查项目,使筛查参与率快速升至国家机构设定的≥80%目标,且可持续,并在短时间内与结直肠癌发病率和死亡率的大幅下降相关,符合早期发现和癌症预防。
研究设计与样本
- 研究对比了大型社区人群中实施有组织筛查外展(2007至2008年,主要为年度粪便免疫化学检测和结肠镜)前(基线2000年)后(至2015年)的筛查率、年龄标化年度结直肠癌发病率和基于发病的死亡率。
- 在51至75岁符合筛查条件的个体中,计算年度结直肠癌筛查最新状态(粪便检测、乙状结肠镜或结肠镜)、结直肠癌发病率、癌症分期分布和基于发病的死亡率。
主要发现
- 筛查最新状态从2000年38.9%升至2015年82.7%(P<.01)。
- 年度结直肠癌发病率从2000年95.8例/10万降至2015年71.4例/10万,降低25.5%(P<.01);癌症死亡率从30.9例/10万降至14.7例/10万,降低52.4%(P<.01)。
- 筛查增加初期与结直肠癌发病率升高相关,主要因早期癌检出增多,随后癌症发病率下降。
- 晚期结直肠癌发病率从45.9例/10万降至29.3例/10万,降低36.2%(P<.01);早期结直肠癌发病率从48.2例/10万降至41.2例/10万,降低14.5%(P<.04)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Little information is available on the effectiveness of organized colorectal cancer (CRC) screening on screening uptake, incidence, and mortality in community-based populations. METHODS: We contrasted screening rates, age-adjusted annual CRC incidence, and incidence-based mortality rates before (baseline year 2000) and after (through 2015) implementation of organized screening outreach, from 2007 through 2008 (primarily annual fecal immunochemical testing and colonoscopy), in a large community-based population. Among screening-eligible individuals 51-75 years old, we calculated annual up-to-date status for cancer screening (by fecal test, sigmoidoscopy, or colonoscopy), CRC incidence, cancer stage distributions, and incidence-based mortality. RESULTS: Initiation of organized CRC screening significantly increased the up-to-date status of screening, from 38.9% in 2000 to 82.7% in 2015 (P < .01). Higher rates of screening were associated with a 25.5% reduction in annual CRC incidence between 2000 and 2015, from 95.8 to 71.4 cases/100,000 (P < .01), and a 52.4% reduction in cancer mortality, from 30.9 to 14.7 deaths/100,000 (P < .01). Increased screening was initially associated with increased CRC incidence, due largely to greater detection of early-stage cancers, followed by decreases in cancer incidence. Advanced-stage CRC incidence rates decreased 36.2%, from 45.9 to 29.3 cases/100,000 (P < .01), and early-stage CRC incidence rates decreased 14.5%, from 48.2 to 41.2 cases/100,000 (P < .04). CONCLUSIONS: Implementing an organized CRC screening program in a large community-based population rapidly increased screening participation to the ≥80% target set by national organizations. Screening rates were sustainable and associated with substantial decreases in CRC incidence and mortality within short time intervals, consistent with early detection and cancer prevention.
引用
- Levin TR, Corley DA, Jensen CD, et al. Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population. Gastroenterology. 2018. PMID: 30031768. doi:10.1053/j.gastro.2018.07.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。